
1. sci rep. 2019 feb 20;9(1):2388. doi: 10.1038/s41598-018-38090-5.

a haemophilus sp. dominates microbiota sputum uk adults with
non-severe community acquired pneumonia chronic lung disease.

wootton dg(1)(2), cox mj(3), gloor gb(4), litt d(5), hoschler k(6), german e(7), 
court j(7), eneje o(7), keogan l(8), macfarlane l(7), wilks s(7), diggle pj(9),
woodhead m(10)(11), moffatt mf(3), cookson woc(3), gordon sb(7)(12).

author information: 
(1)institute infection global health, university liverpool, liverpool, 
uk. dwootton@liverpool.ac.uk.
(2)department respiratory research, aintree university hospital nhs foundation
trust, liverpool, uk. dwootton@liverpool.ac.uk.
(3)section genomic medicine, national heart lung institute, imperial
college london, london, uk.
(4)departments biochemistry applied mathematics, university western
ontario, ontario, on, canada.
(5)respiratory vaccine preventable bacteria reference unit, national
infection service, public health england, london, uk.
(6)virus reference department, national infection service, public health england,
london, uk.
(7)department clinical sciences, liverpool school tropical medicine,
liverpool, uk.
(8)department respiratory research, aintree university hospital nhs foundation
trust, liverpool, uk.
(9)chicas, lancaster university medical school, lancaster university, lancaster, 
uk.
(10)department respiratory medicine, central manchester university hospitals
nhs foundation trust, manchester, uk.
(11)manchester academic health science centre faculty medical human
sciences, university manchester, manchester, uk.
(12)the malawi liverpool wellcome trust clinical research programme, blantyre,
malawi.

the demographics comorbidities patients community acquired pneumonia 
(cap) vary enormously stratified treatment difficult aetiological 
studies failed comprehensively identify pathogens. aim to
describe bacterial microbiota cap relate clinical
characteristics order inform future trials treatment stratified by
co-morbidity. cap patients prospectively recruited two uk hospitals. we
used 16s rrna gene sequencing identify dominant bacteria sputum and
compositional data analysis determine associations patient
characteristics. analysed sputum samples 77 patients found a
streptococcus sp. haemophilus sp. relatively abundant
pathogens. haemophilus sp. likely dominant patients with
pre-existing lung disease, relative abundance associated qpcr
levels haemophilus influenzae. abundant streptococcus sp. was
associated qpcr levels streptococcus pneumoniae dominance could not
be predicted clinical characteristics. data suggest chronic lung
disease influences microbiota sputum patients cap. finding
could inform trial stratifying empirical cap antibiotics target
haemophilus spp. addition streptococcus spp. chronic lung
disease.

doi: 10.1038/s41598-018-38090-5 
pmcid: pmc6382935
pmid: 30787368  [indexed medline]

